lung cancer
play

Lung Cancer American Cancer Society Reviewed February 2017 So what - PowerPoint PPT Presentation

May 07, 2023 •282 likes •587 views

Lung Cancer American Cancer Society Reviewed February 2017 So what can you do to prevent lung cancer? Thank you!

  1. Lung Cancer American Cancer Society Reviewed February 2017

  18. So what can you do to prevent lung cancer?

  29. Thank you!

Recommend

Controversies in the surgical management of lung cancer 14 th Annual Winter Lung Cancer

Controversies in the surgical management of lung cancer 14 th Annual Winter Lung Cancer

Controversies in the surgical management of lung cancer 14 th Annual Winter Lung Cancer Conference Miami, Feb 12 2017 Eric Vallires MD FRCSC Medical Director Division of Thoracic Surgery Swedish Cancer Institute Seattle, WA CASE:

566 views • 41 slides
Lung Cancer : Lung Cancer : Lung Cancer : Lung Cancer : Improving the Cure Rate Improving the

Lung Cancer : Lung Cancer : Lung Cancer : Lung Cancer : Improving the Cure Rate Improving the

Lung Cancer : Lung Cancer : Lung Cancer : Lung Cancer : Improving the Cure Rate Improving the Cure Rate with Radiation with Radiation ith R di ti ith R di ti Andrea Andrea Bezjak Bezjak , MDCM, MSc, FRCPC The Addie MacNaughton Chair in

649 views • 54 slides
Lung Cancer Objectives To provide a general overview of lung physiology To explore the types and

Lung Cancer Objectives To provide a general overview of lung physiology To explore the types and

Lung Cancer Objectives To provide a general overview of lung physiology To explore the types and classifications of lung cancer To provide causes and risk factors of lung cancer To present the signs and symptoms of lung cancer in throughout

682 views • 40 slides
Lung Cancer Screening and the Women of Tennessee Kim. L. Sandler, MD Co-Director, Lung

Lung Cancer Screening and the Women of Tennessee Kim. L. Sandler, MD Co-Director, Lung

Lung Cancer Screening and the Women of Tennessee Kim. L. Sandler, MD Co-Director, Lung Screening Program Lung cancer kills more women than breast & ovarian cancer combined 27,000 Mammograms in 2018 Lung Screening Missing 80 % 60

311 views • 27 slides
Prognostic molecular models in early-stage lung cancer 14 th Annual Winter Lung Cancer Conference

Prognostic molecular models in early-stage lung cancer 14 th Annual Winter Lung Cancer Conference

Prognostic molecular models in early-stage lung cancer 14 th Annual Winter Lung Cancer Conference Miami, Feb 12 2017 Eric Vallires MD FRCSC Medical Director Division of Thoracic Surgery Swedish Cancer Institute Seattle, WA CASE I: AC OR

610 views • 26 slides
Improving the implementation of lung cancer screening guidelines at UNC DANIEL S. REULAND, MD,

Improving the implementation of lung cancer screening guidelines at UNC DANIEL S. REULAND, MD,

Improving the implementation of lung cancer screening guidelines at UNC DANIEL S. REULAND, MD, MPH IHQI SEED GRANT SYMPOSIUM MAY 24, 2016 Background Lung cancer is the leading cause of cancer mortality in US Lung cancer screening with

379 views • 34 slides
LUNG CANCER SCREENING IMPROVING LUNG CANCER SURVIVAL IN THE COMMUNITY SETTING Scott Skibo, MD,

LUNG CANCER SCREENING IMPROVING LUNG CANCER SURVIVAL IN THE COMMUNITY SETTING Scott Skibo, MD,

8/19/2018 LUNG CANCER SCREENING IMPROVING LUNG CANCER SURVIVAL IN THE COMMUNITY SETTING Scott Skibo, MD, FCCP Haywood Regional Medical Center Duke LifePoint 1 8/19/2018 PRACTICE LOCATION 159 Bed Hospital 2 8/19/2018 At present, lung

465 views • 33 slides
Navigating patients through lung cancer treatment Kirsten Mooney -Thoracic Cancer Nurse

Navigating patients through lung cancer treatment Kirsten Mooney -Thoracic Cancer Nurse

Navigating patients through lung cancer treatment Kirsten Mooney -Thoracic Cancer Nurse Coordinators Caitlin Broderick Lung Cancer an overview Most recent stats from WA Cancer Registry (2013) Incidence 1000 cases, Death 788

330 views • 15 slides
Lung Cancer Diagnosis in 2007 Greatest cause of cancer deaths worldwide Greatest cause of

Lung Cancer Diagnosis in 2007 Greatest cause of cancer deaths worldwide Greatest cause of

Lung Cancer Statistics, 2007 Lung Cancer Diagnosis in 2007 Greatest cause of cancer deaths worldwide Greatest cause of cancer deaths in U.S. Cancer Incidence/Mortality 2006 Patrick Nana-Sinkam ,MD, FACP 210,000 new 250000 cases in

389 views • 20 slides
Outline Changing lung cancer epidemiology and demographics EGFR-mutant lung cancer diagnosis and

Outline Changing lung cancer epidemiology and demographics EGFR-mutant lung cancer diagnosis and

UCSF Continuing Medical Education Disclosures Revolution Medicines Consulting AstraZeneca Research Funding Novartis Research Funding Lung Cancer in Non-Smokers Roche Research Funding Mirati Research Funding Takeda Research Funding

337 views • 9 slides
2011 Trial Update RTOG Lung Cancer Committee Chair: Jeffrey Bradley, M.D. Kling Associate

2011 Trial Update RTOG Lung Cancer Committee Chair: Jeffrey Bradley, M.D. Kling Associate

RTOG Lung Cancer 2011 Trial Update RTOG Lung Cancer Committee Chair: Jeffrey Bradley, M.D. Kling Associate Professor Department of Radiation Oncology Washington University School of Medicine RTOG Lung Committee Small Cell Lung Cancer

913 views • 55 slides
Slide 1 ___________________________________ Next Generation Lung Cancer

Slide 1 ___________________________________ Next Generation Lung Cancer

Slide 1 ___________________________________ Next Generation Lung Cancer ___________________________________ Medicine 12 th International Lung Cancer Congress ___________________________________ 4 th Annual Addario Lectureship Award Carlsbad,

397 views • 14 slides
Lung cancer in the elderly D. Schrijvers, MD, PhD Ziekenhuisnetwerk Antwerpen(ZNA)-Middelheim

Lung cancer in the elderly D. Schrijvers, MD, PhD Ziekenhuisnetwerk Antwerpen(ZNA)-Middelheim

Lung cancer in the elderly D. Schrijvers, MD, PhD Ziekenhuisnetwerk Antwerpen(ZNA)-Middelheim Antwerp Belgium I ncidence and m ortality of all cancers and lung cancer in relation to age and gender ( US) 120,000 50,000 Number of patients

473 views • 31 slides
Lung cancer in Europe Alan Lovell The Economist Intelligence Unit Healthcare Biggest cancer

Lung cancer in Europe Alan Lovell The Economist Intelligence Unit Healthcare Biggest cancer

4 December 2018 Lung cancer in Europe Alan Lovell The Economist Intelligence Unit Healthcare Biggest cancer killer in Europe DALYs for top 5 cancers in Europe: trend over time Source: EIU. Original data compiled from GBD Lung cancer in

686 views • 35 slides
Slide 1 ___________________________________ RTOG Lung Cancer ___________________________________

Slide 1 ___________________________________ RTOG Lung Cancer ___________________________________

Slide 1 ___________________________________ RTOG Lung Cancer ___________________________________ 2011 Trial Update ___________________________________ RTOG Lung Cancer Committee Chair: Jeffrey Bradley, M.D. Kling Associate Professor

461 views • 19 slides
Estimated Cancer Deaths, U.S., 2019 Men Women Lung & bronchus 76,650 Lung & bronchus

Estimated Cancer Deaths, U.S., 2019 Men Women Lung & bronchus 76,650 Lung & bronchus

Use of Low Dose CT Scanning for Early Lung Cancer Detection Among High Risk Workers Steven Markowitz MD, DrPH Barry Commoner Center, CUNY Updates In Environmental and Occupational Medicine UCSF School of Medicine March 7, 2020 Disclosure

524 views • 23 slides
Mesothelioma Trends as Predictors of the Asbestos- Related Lung Cancer Burden Valerie McCormack

Mesothelioma Trends as Predictors of the Asbestos- Related Lung Cancer Burden Valerie McCormack

Mesothelioma Trends as Predictors of the Asbestos- Related Lung Cancer Burden Valerie McCormack UICC World Cancer Congress Montreal August 2012 Outline Background Estimating the lung cancer mortality burden Caveats

184 views • 15 slides
ADDRESSING LUNG CANCER STIGMA Katherine Pruitt National Assistant Vice President of Health

ADDRESSING LUNG CANCER STIGMA Katherine Pruitt National Assistant Vice President of Health

ADDRESSING LUNG CANCER STIGMA Katherine Pruitt National Assistant Vice President of Health Education April 13, 2016 1 1 ABOUT THE AMERICAN LUNG ASSOCIATION Our Mission: To save lives by improving lung health and preventing lung disease. Our

261 views • 9 slides
HOW TO TALK TO PEOPLE WITH LUNG CANCER? Lee Ann Jarrett Johnson PhD, RN Assistant Professor

HOW TO TALK TO PEOPLE WITH LUNG CANCER? Lee Ann Jarrett Johnson PhD, RN Assistant Professor

OVERCOMING STIGMA: HOW TO TALK TO PEOPLE WITH LUNG CANCER? Lee Ann Jarrett Johnson PhD, RN Assistant Professor East Carolina University INTERACTIVE QUESTION You say: My Mom has lung cancer. The response you hear is? WHAT IS STIGMA?

593 views • 35 slides
Addressing Current Questions and Controversies in the Management of Non-Small Cell Lung Cancer

Addressing Current Questions and Controversies in the Management of Non-Small Cell Lung Cancer

Addressing Current Questions and Controversies in the Management of Non-Small Cell Lung Cancer with an EGFR Mutation A Live CME Webinar During the IASLC 2020 North America Virtual Conference on Lung Cancer Friday, October 16, 2020 11:00 AM

1.1k views • 85 slides
Prioritizing Therapeutics for Lung Cancer: An Integrative Meta-analysis of Cancer Gene

Prioritizing Therapeutics for Lung Cancer: An Integrative Meta-analysis of Cancer Gene

Prioritizing Therapeutics for Lung Cancer: An Integrative Meta-analysis of Cancer Gene Signatures and Chemogenomic Data Fortney et al. Presented by Erkin Otles Approach Identify drugs that reverse gene expression signature of a disease

200 views • 17 slides
5/1/2009 Do we need biopsy to treat early inoperable lung cancer? Frank J. Lagerwaard MD PhD VU

5/1/2009 Do we need biopsy to treat early inoperable lung cancer? Frank J. Lagerwaard MD PhD VU

5/1/2009 Do we need biopsy to treat early inoperable lung cancer? Frank J. Lagerwaard MD PhD VU University medical center Amsterdam, The Netherlands Perspectives in Lung Cancer, Bruxelles, 2009 VUmc Amsterdam Pathological verification of malignancy

444 views • 9 slides
Updates in Lung Cancer from ASCO 2016 Alectinib versus Crizotinib in ALK Inhibitor Nave

Updates in Lung Cancer from ASCO 2016 Alectinib versus Crizotinib in ALK Inhibitor Nave

7/20/2016 Updates in Lung Cancer from ASCO 2016 Alectinib versus Crizotinib in ALK Inhibitor Nave ALK-Positive Non-Small Cell Lung Cancer:<br /> Primary Results from the J-ALEX Study Presented By Hiroshi Nokihara at 2016 ASCO Annual

568 views • 35 slides
Pharmacogenomic markers in EGFR-targeted therapy of lung cancer Rafal Dziadziuszko, MD, PhD

Pharmacogenomic markers in EGFR-targeted therapy of lung cancer Rafal Dziadziuszko, MD, PhD

Pharmacogenomic markers in EGFR-targeted therapy of lung cancer Rafal Dziadziuszko, MD, PhD University of Colorado Cancer Center, Aurora, CO, USA Medical University of Gdansk, Poland EMEA Workshop on Biomarkers, 15 December 2006 Cancer

498 views • 28 slides

More recommend